[The effect of molsidomine on the conjunctival microcirculation in patients with ischemic heart disease].
Sublingual administration of molsidomin in average dose of 3 mg with an interval of 15 and 60 minutes was used in the treatment of 24 patients with ischemic heart disease with stable exertion stenocardia of the II-III functional classes. Course treatment in optimal chosen doses resulted in an improvement of the indices of conjunctival microcirculation and rheological properties of erythrocytes.
Brovko
E A
EA
Denisiuk
V I
VI
Kolesnik
P F
PF
D000328:Adult; D000368:Aged; D000787:Angina Pectoris / Q000188:drug therapy / Q000503:physiopathology; D003228:Conjunctiva / Q000098:blood supply / Q000187:drug effects*; D003327:Coronary Disease / Q000188:drug therapy* / Q000503:physiopathology; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D008297:Male; D008833:Microcirculation / Q000187:drug effects / Q000502:physiology; D008875:Middle Aged; D008981:Molsidomine / Q000627:therapeutic use*; D013997:Time Factors
D008981:Molsidomine
Vliianie molsidomina na kon''iunktival'nuiu mikrotsirkuliatsiiu u bol'nykh ishemicheskoĭ bolezn'iu serdtsa.